Previous 10 | Next 10 |
Gainers: DRTT +7.9% . EGO +3.2% . AU +1.9% . OBSV +1.7% . More news on: Eldorado Gold Corporation, AngloGold Ashanti Limited, ObsEva SA, Stocks on the move, Read more ...
Livongo Health (NASDAQ: LVGO ) +22% after Q3 results . More news on: Livongo Health, Inc., DexCom, Inc., InflaRx N.V., Stocks on the move, Read more ...
Image source: The Motley Fool. TherapeuticsMD Inc (NASDAQ: TXMD) Q3 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
TherapeuticsMD, Inc. (TXMD) Q3 2019 Earnings Conference Call November 06, 2019 04:30 PM ET Company Participants Nichol Ochsner - Vice President, Investor Relations Robert Finizio - Chief Executive Officer Dan Cartwright - Chief Financial Officer Dawn Halkuff - Chief Commercial ...
The following slide deck was published by TherapeuticsMD, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Therapeutics MD (NASDAQ: TXMD ): Q3 GAAP EPS of -$0.13 beats by $0.06 . Revenue of $23.7M (+583.0% Y/Y) beats by $15.65M . Press Release More news on: TherapeuticsMD, Inc., Earnings news and commentary, Healthcare stocks news,
- 3Q19 Net Revenue (Product and License) Increased to $23.7 Million - - 3Q19 Product Net Revenue Increased 34% to $8.2 Million Compared to 2Q19- - The Company Reaffirms 4Q19 Financial Guidance - - Conference Call Scheduled for 4:30 p.m. ET Today - TherapeuticsMD, Inc. (NASDAQ: T...
Therapeutics MD (NASDAQ: TXMD ) is scheduled to announce Q3 earnings results on Wednesday, November 6th, after market close. The consensus EPS Estimate is -$0.19 (-18.8% Y/Y) and the consensus Revenue Estimate is $8.05M (+130.0% Y/Y). Over the last 1 year, txmd has beaten EPS estimate...
-Executive Management to Host Conference Call on November 6, 2019 at 4:30 p.m. ET- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its third quarter 2019 financial results on Wednesday, November 6, 2019, after the ...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...